S&P 500 slips, but losses kept in check as Nvidia climbs ahead of results
On May 19, the Jon I. Madorsky Revocable Trust executed a notable transaction involving the sale of P10, Inc. (NYSE:PX) stock. The trust sold 10,000 shares of P10’s Class A Common Stock at a price of $12 per share, resulting in a total transaction value of $120,000. The sale price was slightly above the current trading price of $11.67, with InvestingPro data showing the stock is currently trading near its Fair Value. Following this sale, the trust retains ownership of 495,574 shares.
The transaction was reported by the trust, with Jon I. Madorsky acting as trustee, and was filed with the SEC on May 21. While the trust is not directly an officer or director of P10, it is considered part of a group that collectively holds more than 10% of the company’s common stock.
In other recent news, P10 Inc reported its first quarter 2025 earnings, which fell short of expectations. The company announced an earnings per share (EPS) of $0.04, significantly below the forecasted $0.21, and revenue of $67.7 million, which also missed the expected $70.1 million. Additionally, P10 Inc’s adjusted net income decreased by 8% year-over-year to $23.5 million. Despite these setbacks, the company’s fee-paying assets under management grew by 10% year-over-year, reaching $26.3 billion, driven by strategic acquisitions and successful fundraising efforts. JPMorgan analyst Kenneth Worthington revised the price target for P10 Inc to $14.50, down from $15.00, but maintained an Overweight rating. Worthington noted several positive developments, including increased transparency, corporate governance enhancements, and strategic mergers and acquisitions, such as the acquisition of European solutions provider Qualitas. P10 Inc’s management remains optimistic about its growth trajectory, anticipating double-digit revenue growth in 2025 and aiming to raise $4 billion in organic gross fundraising.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.